drugset / Trial / NCT02040415
Phase 3 Study to Evaluate the Efficacy and Safety of DW-1030 and Eperisone HCl in Acute Back Pain Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this clinical study is to determine whether or not DW-1030 is not inferior to eperisone HCl in efficacy and safety.
Timeline
- Start
- 2014-03
- Primary completion
- 2014-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eperisone | Small molecule | 50 mg | — |
| Subject | Eperisone | Small molecule | 75 mg | — |
Indications
No indication recorded.